VITASPRING BIOMEDICAL CO., LTD. (VSBC) Shareholders’ equity 2017–2026
VITASPRING BIOMEDICAL CO., LTD. (VSBC) shareholders’ equity at each fiscal year-end, per SEC filings.
-$4.4MFY2026 · since FY2017: $2,955 → -$4.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.4M | -10.3% |
| FY2025 | -$4.0M | -19.8% |
| FY2024 | -$3.4M | -39.8% |
| FY2023 | -$2.4M | -251.9% |
| FY2022 | $1.6M | +1537.1% |
| FY2021 | $96,364 | — |
| FY2020 | $0 | +100.0% |
| FY2019 | -$6,919 | -102.4% |
| FY2018 | -$3,419 | -215.7% |
| FY2017 | $2,955 | — |
Source: SEC XBRL filings · For reference only · Not investment advice